床旁脑自动调节功能的测定:叙述性综述
该叙述性综述汇总了重症监护环境下脑自动调节(CAR)监测技术的现有证据,检索了Ovid MEDLINE、PubMed和Cochrane图书馆,纳入关注床旁CAR监测方法、验证及其在危重症患者中应用的原研研究、综述、评论和指南,涵盖急性脑损伤与全身性危重症。综述识别出三种常用床旁CAR评估方法:经颅多普勒超声测量血管流速对血压变化的反应(通过给予血管升压药或监测自发波动)、近红外光谱通过连续无创额部传感器评估区域脑氧合对血流动力学变化的反应、颅内压监测通过分析颅内压与动脉血压的相关性评估压力反应指数。CAR受损在危重症中常见,从急性脑损伤到脓毒症、心脏手术、肝衰竭等全身性疾病,调节障碍可导致继发性脑损伤和更差结局;各技术在侵入性、连续监测能力和技术要求方面不同。证据提示这些方法有助于检测CAR受损、识别最佳灌注目标,并可能指导个体化管理策略。结论认为床旁CAR监测是危重症患者血流动力学个体化管理的有前景的方法,当前证据支持其在预后判断和管理决策中的作用,但需进一步研究标准化评估方法并在不同重症条件下验证CAR指导的治疗;多模态监测方法可能提供互补信息以优化患者照护。
要点
- 三种常用床旁CAR评估方法:经颅多普勒超声测流速对血压变化的反应、近红外光谱测区域脑氧合对血流动力学变化的反应、颅内压监测计算压力反应指数。
- CAR受损在危重症中常见,从急性脑损伤到脓毒症、心脏手术、肝衰竭等全身性疾病,调节障碍可导致继发性脑损伤和更差结局。
- 各技术侵入性、连续监测能力和技术要求不同,证据提示这些方法有助于检测CAR受损、识别最佳灌注目标并可能指导个体化管理策略。
- 当前证据支持床旁CAR监测在预后判断和管理决策中的作用,但需进一步研究标准化评估方法并在不同重症条件下验证CAR指导的治疗。
- 多模态监测方法可能提供互补信息以优化患者照护。
适用人群与场景
- 重症监护环境中的危重症患者,涵盖急性脑损伤与全身性危重症(如脓毒症、心脏手术、肝衰竭)。
处置流程与药物剂量
- 经颅多普勒超声:通过给予血管升压药或监测自发波动,测量血管流速对血压变化的反应以评估CAR。
- 近红外光谱:通过连续、无创额部传感器评估区域脑氧合对血流动力学变化的反应以评估CAR。
- 颅内压监测:通过分析颅内压与动脉血压的相关性计算压力反应指数以评估CAR。
研究设计与关键结果
- 叙述性综述,检索Ovid MEDLINE、PubMed和Cochrane图书馆,纳入关注床旁CAR监测方法、验证及其在危重症患者中应用的原研研究、综述、评论和指南,涵盖急性脑损伤与全身性危重症。
- 识别出三种常用床旁CAR评估方法:经颅多普勒超声、近红外光谱、颅内压监测衍生压力反应指数。
- CAR受损在危重症中常见,从急性脑损伤到脓毒症、心脏手术、肝衰竭等全身性疾病,调节障碍可导致继发性脑损伤和更差结局。
- 各技术在侵入性、连续监测能力和技术要求方面不同;证据提示这些方法有助于检测CAR受损、识别最佳灌注目标,并可能指导个体化管理策略。
证据类型、等级与局限
- 证据类型:叙述性综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 床旁CAR监测是危重症患者血流动力学个体化管理的有前景的方法,当前证据支持其在预后判断和管理决策中的作用。
- 需进一步研究标准化评估方法并在不同重症条件下验证CAR指导的治疗。
- 多模态监测方法可能提供互补信息以优化患者照护。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To summarize the current evidence on cerebral autoregulation (CAR) monitoring techniques in critical care settings, highlighting their advantages, limitations, and practical applications at the bedside to inform understanding and clinical decision-making for various acute brain injuries and systemic illnesses.
DATA SOURCES: Articles were retrieved using Ovid MEDLINE, PubMed, and Cochrane library using a comprehensive combination of subject headings and key words including "cerebral autoregulation," "transcranial Doppler," "near-infrared spectroscopy," and "intracranial pressure." See Supplemental Appendix A ( https://links.lww.com/CCM/H763 ) for complete list of search terms. Relevant articles as well as those discovered through the review process (e.g., references in selected articles) were incorporated into the article.
STUDY SELECTION: Original research, review articles, commentaries, and guidelines focusing on bedside CAR monitoring methodologies, their validation, and applications in critically ill patients were included. The review encompassed both acute brain injury and systemic critical illness conditions.
DATA EXTRACTION: Data from included publications were evaluated and synthesized into a comprehensive narrative review examining CAR monitoring methods and clinical applications.
DATA SYNTHESIS: Three commonly used bedside approaches for assessing CAR were identified. Transcranial Doppler ultrasound measures vessel flow velocity response to blood pressure changes, either through vasopressor administration or monitoring spontaneous fluctuations. Near-infrared spectroscopy evaluates regional cerebral oxygenation changes in response to hemodynamic alterations through continuous, noninvasive forehead sensors. Intracranial pressure monitoring enables assessment of pressure reactivity index through analyzing the correlation between intracranial and arterial blood pressure. CAR impairment is common across critical illness, from acute brain injury to systemic conditions like sepsis, cardiac surgery, and hepatic failure, where dysregulation can lead to secondary brain injury and worse outcomes. While each technique offers unique insights into CAR status, they vary in invasiveness, continuous monitoring capability, and technical requirements. Evidence suggests these methods can help to detect impaired CAR, identify optimal perfusion targets, and may guide individualized management strategies.
CONCLUSIONS: Bedside CAR monitoring represents a promising approach for personalizing hemodynamic management in critically ill patients. While current evidence supports its role in prognostication and management decisions, further research is needed to standardize assessment methods and validate CAR-guided therapy across different critical care conditions. Multimodal monitoring approaches may provide complementary information to optimize patient care.
参考来源
- Vitt JR, Tsetsou S, Galarza L, et al. Determination of Cerebral Autoregulation at the Bedside: A Narrative Review. Crit Care Med. 2025. PMID: 40826313. doi:10.1097/CCM.0000000000006790
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。